Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis

Infliximab Use in a Child with Ulcerative Colitis and Prior in utero Exposure to Infliximab

(2020) Jessica Lim et al.   GASTROENTEROLOGY

P509 Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease

(2020) W Sun et al.   Journal of Crohns & Colitis

P538 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis treated with ustekinumab

(2020) A Geldhof et al.   Journal of Crohns & Colitis

Anti‐TNF treatment during pregnancy and birth outcomes: A population‐based study from Denmark, Finland, and Sweden

(2020) Gabriella Bröms et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study

(2020) Han H. Lee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Sa1857 EARLY DISCONTINUATION OF ADALIMUMAB THERAPY IN IBD PREGNANCY

(2020) Brindusa Truta et al.   GASTROENTEROLOGY

Sa1852 VEDOLIZUMAB DRUG LEVELS IN MATERNAL AND CORD BLOOD FOLLOWING TREATMENT OF INFLAMMATORY BOWEL DISEASE IN PREGNANCY: ONGOING MULTICENTRE PROSPECTIVE STUDY FROM THE CZECH REPUBLIC

(2020) Barbora Pipek et al.   GASTROENTEROLOGY

Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease

(2020) Sang Hyoung Park et al.   Journal of Crohns & Colitis

Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use

(2020) James D Triplett et al.   Multiple Sclerosis and Related Disorders

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

(2020) Andrea Ines Ciplea et al.   Neurology-Neuroimmunology & Neuroinflammation

Oral corticosteroids and risk of preterm birth in the California Medicaid Program

(2020) Kristin Palmsten et al.   Journal of Allergy and Clinical Immunology-In Practice

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

(2020) Emma Flanagan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy: A Systematic Review and Meta-analysis

(2020) Ole Haagen Nielsen et al.   Clinical Gastroenterology and Hepatology

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

(2020) Uma Mahadevan et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway – A Report from the American Gastroenterological Association IBD Parenthood Project Working Group

(2019) Uma Mahadevan et al.   GASTROENTEROLOGY

Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study

(2019) Maria C Magnus et al.   BMJ-British Medical Journal

Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant

(2019) Benjamin Koslowsky et al.   DIGESTIVE DISEASES AND SCIENCES

Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate

(2019) Ariella Bar-Gil Shitrit et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

(2019) Christopher Andrew Lamb et al.   GUT

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

(2019) Annick Moens et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ERS/TSANZ Task Force Statement on the Management of Reproduction and Pregnancy in Women with Airways Diseases

(2019) Peter G. Middleton et al.   EUROPEAN RESPIRATORY JOURNAL

Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease

(2019) Brindusa Truta et al.   INFLAMMATORY BOWEL DISEASES

Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications

(2019) Sangmin Lee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

(2018) J. L. Damman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

(2018) Gary R. Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)

(2018) Maxime Luu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

(2018) M Chaparro et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prolonged Persistence of Adalimumab Transferred From Mother to Infant During Pregnancy

(2018) Remi Labetoulle et al.   ANNALS OF INTERNAL MEDICINE

Methotrexate Reduces DNA Integrity in Sperm From Men With Inflammatory Bowel Disease

(2018) Dana Ley et al.   GASTROENTEROLOGY

Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development

(2018) Rebecca Matro et al.   GASTROENTEROLOGY

Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

(2018) Mette Julsgaard et al.   GASTROENTEROLOGY

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis

(2018) Uma Mahadevan et al.   INFLAMMATORY BOWEL DISEASES

Prednisone Pharmacokinetics During Pregnancy and Lactation

(2018) Rachel J. Ryu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

P072 Safety analysis of vedolizumab during pregnancy: Findings from a reproductive study in monkeys

(2018) D Crawford et al.   Journal of Crohns & Colitis

Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type

(2018) Shannon L Kanis et al.   Journal of Crohns & Colitis

Pregnancy Outcomes Following Exposure to Quinolone Antibiotics – a Systematic-Review and Meta-Analysis

(2018) Aviva Ziv et al.   PHARMACEUTICAL RESEARCH

Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system

(2018) Jantien W. Wieringa et al.   Expert Review of Gastroenterology & Hepatology

Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants

(2018) Michael G. Kattah et al.   Clinical and Translational Gastroenterology

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation

(2018) Dana Duricova et al.   INFLAMMATORY BOWEL DISEASES

The teratogenicity of allopurinol: A comprehensive review of animal and human studies

(2018) Melek Simsek et al.   REPRODUCTIVE TOXICOLOGY

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

(2018) Emma Flanagan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

(2018) Annick Moens et al.   Journal of Crohns & Colitis

Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease

(2018) Entcho Klenske et al.   Journal of Crohns & Colitis

Optimal Anti-TNF Stop Week during Pregnancy Depends on Anti-TNF Type

(2017) Shannon L. Kanis et al.   GASTROENTEROLOGY

Placental MadCAM1 Expression and Potential Consequences for the Treatment with Vedolizumab during Pregnancy

(2017) Zuzana Zelinkova et al.   GASTROENTEROLOGY

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease

(2017) Uma Mahadevan et al.   GASTROENTEROLOGY

Vedolizumab safety in pregnancy and newborn outcomes

(2017) Mette Julsgaard et al.   GUT

The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure

(2017) Anne Grosen et al.   INFLAMMATORY BOWEL DISEASES

The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease

(2017) Heidi Kammerlander et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

(2017) Adi Lahat et al.   Journal of Crohns & Colitis

Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation

(2017) Catherine R Rowan et al.   Journal of Crohns & Colitis

Transplacental passage of vancomycin

(2017) Craig V. Towers et al.   Journal of Maternal-Fetal & Neonatal Medicine

Natalizumab during pregnancy and lactation

(2017) Undine Proschmann et al.   Multiple Sclerosis Journal

A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes

(2017) Gretchen Bandoli et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Natalizumab during pregnancy and lactation

(2017) Undine Proschmann et al.   Multiple Sclerosis Journal

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

(2016) Carina Götestam Skorpen et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study

(2016) Susan Friend et al.   BMC Neurology

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

(2016) Megan E. B. Clowse et al.   DRUG SAFETY

Treatment of rheumatoid arthritis during pregnancy: present and future

(2016) Frauke Förger et al.   Expert Review of Clinical Immunology

437 Do Infant Serum Levels of Biologic Agents at Birth Correlate With Risk of Adverse Outcomes? Results From the PIANO Registry

(2016) Uma Mahadevan et al.   GASTROENTEROLOGY

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

(2016) Mette Julsgaard et al.   GASTROENTEROLOGY

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

(2016) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis

(2016) Andrea L. Matthis et al.   INFLAMMATORY BOWEL DISEASES

Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitis

(2016) C. J. Kiely et al.   INTERNAL MEDICINE JOURNAL

Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature

(2016) X. Cortes et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease

(2016) Zane R. Gallinger et al.   Journal of Crohns & Colitis

Differences in Cytokine Expression and STAT3 Activation between Healthy Controls and Patients of Unexplained Recurrent Spontaneous Abortion (URSA) during Early Pregnancy

(2016) JunYing Cai et al.   PLoS One

Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

(2015) M. Rosario et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Natalizumab for Crohn’s Disease: Down but Not Out

(2015) Frank I. Scott et al.   Clinical Gastroenterology and Hepatology

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety

(2015) A de Lima et al.   GUT

Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease

(2015) Mohammed Sheikh et al.   Journal of Crohns & Colitis

Intrapartum Corticosteroid use Significantly Increases the Risk of Gestational Diabetes in Women with Inflammatory Bowel Disease

(2015) Yvette P. Y. Leung et al.   Journal of Crohns & Colitis

Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease

(2015) Sophie A. van den Berg et al.   Journal of Crohns & Colitis

Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis

(2015) E. Galli-Novak et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Self-reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease

(2015) M. J. Nielsen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Su1030 Is Asacol Use Associated With Congenital Anomalies? Results From a Nationwide Prospective Pregnancy Registry

(2015) Aparajita Singh et al.   GASTROENTEROLOGY

Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease

(2014) P. Deepak et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

(2014) M. Seirafi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Transplacental passage of vancomycin from mother to neonate

(2014) Cheryl N. Onwuchuruba et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Corticosteroid use and risk of orofacial clefts

(2014) Hildur Skuladottir et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

2 Pregnancy Outcomes Amongst Mothers With Inflammatory Bowel Disease Exposed to Systemic Corticosteroids: Results of the PIANO Registry

(2014) Kirk Lin et al.   GASTROENTEROLOGY

Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs

(2014) S Mozaffari et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease

(2014) Neeraj Narula et al.   INFLAMMATORY BOWEL DISEASES

Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children

(2014) Martin Bortlik et al.   INFLAMMATORY BOWEL DISEASES

Splitting a Therapeutic Dose of Thioguanine May Avoid Liver Toxicity and Be an Efficacious Treatment for Severe Inflammatory Bowel Disease

(2014) Polychronis Pavlidis et al.   INFLAMMATORY BOWEL DISEASES

Methotrexate Use in a Breastfeeding Patient with Rheumatoid Arthritis

(2014) J. C. THORNE et al.   JOURNAL OF RHEUMATOLOGY

Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study

(2014) Neda Ebrahimi et al.   Multiple Sclerosis Journal

Anti-TNF-  Therapy May Cause Neonatal Neutropenia

(2014) T. Guiddir et al.   PEDIATRICS

Safety of Tacrolimus Treatment during Pregnancy and Lactation in Systemic Lupus Erythematosus: A Report of Two Patients

(2014) Yasumori Izumi et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Natalizumab Use During the Third Trimester of Pregnancy

(2014) Aiden Haghikia et al.   JAMA Neurology

Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study

(2014) Corinna Weber-Schoendorfer et al.   Arthritis & Rheumatology

Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

(2013) T. G. J. de Meij et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

(2013) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series

(2013) Muhammad W Fazal et al.   BMC GASTROENTEROLOGY

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

(2013) Ole Haagen Nielsen et al.   BMC Medicine

Ciclosporin Use During Pregnancy

(2013) Karolina Paziana et al.   DRUG SAFETY

Limited Risks of Major Congenital Anomalies in Children of Mothers With IBD and Effects of Medications

(2013) Lu Ban et al.   GASTROENTEROLOGY

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease

(2013) Bindia Jharap et al.   GUT

Modifiable Factors Associated with Nonadherence to Maintenance Medication for Inflammatory Bowel Disease

(2013) Christian P. Selinger et al.   INFLAMMATORY BOWEL DISEASES

Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity

(2013) Maria Hoeltzenbein et al.   PLoS One

Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study

(2013) Orna Diav-Citrin et al.   REPRODUCTIVE TOXICOLOGY

Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review

(2013) Renée M Marchioni   WORLD JOURNAL OF GASTROENTEROLOGY

Use of Corticosteroids in Early Pregnancy is Not Associated With Risk of Oral Clefts and Other Congenital Malformations in Offspring

(2012) Anne-Mette Bay Bjørn et al.   AMERICAN JOURNAL OF THERAPEUTICS

Investigation of Metronidazole Use during Pregnancy and Adverse Birth Outcomes

(2012) Catherine A. Koss et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study

(2012) R.T. Woolf et al.   BRITISH JOURNAL OF DERMATOLOGY

Short- and long-term effects of exposure to natural and synthetic glucocorticoids during development

(2012) Reetu R Singh et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

(2012) Zuzana Zelinkova et al.   Clinical Gastroenterology and Hepatology

Safe Use of Allopurinol and Low-dose Mercaptopurine Therapy During Pregnancy in an Ulcerative Colitis Patient

(2012) M.L. Seinen et al.   INFLAMMATORY BOWEL DISEASES

Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease

(2012) Mona Akbari et al.   INFLAMMATORY BOWEL DISEASES

Infliximab and Adalimumab Use During Breastfeeding

(2012) Juliane Fritzsche et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

(2012) J. R. Hutson et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Discovery and mechanism of ustekinumab

(2012) Jacqueline M. Benson et al.   mAbs

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

(2011) Z. Zelinkova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)

(2011) V. Chouraki et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

(2011) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Potential teratogenic effects of allopurinol: A case report

(2011) Mariya Kozenko et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Corticosteroid use during pregnancy and risk of orofacial clefts

(2011) A. Hviid et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Cyclosporine in the management of severe ulcerative colitis while breast-feeding

(2011) Conor Lahiff et al.   INFLAMMATORY BOWEL DISEASES

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

(2011) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease

(2011) Shomron Ben-Horin et al.   Journal of Crohns & Colitis

Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31

(2011) Casper Steenholdt et al.   Journal of Crohns & Colitis

Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation

(2011) Yoon-Soo Cindy Bae et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

CYCLOSPORINE AND LACTATION

(2011) Adam Morton   NEPHROLOGY

Natalizumab (Tysabri)

(2010) D.T. Selewski et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation

(2010) Pauline L. Martin et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy

(2010) P de Graaf et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

(2010) J. Coelho et al.   GUT

Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden

(2010) Olof Stephansson et al.   INFLAMMATORY BOWEL DISEASES

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding

(2010) Sieglinde Angelberger et al.   Journal of Crohns & Colitis

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: A case–control study

(2010) Tamás Molnár et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Early pregnancy azathioprine use and pregnancy outcomes

(2009) Brian J. Cleary et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor

(2009) Nancy G. Wehner et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Adalimumab Level in Breast Milk of a Nursing Mother

(2009) Shomron Ben–Horin et al.   Clinical Gastroenterology and Hepatology

The safety of quinolones—A meta-analysis of pregnancy outcomes

(2009) Benjamin Bar-Oz et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy

(2009) Julien Branche et al.   INFLAMMATORY BOWEL DISEASES

Azathioprine treatment during lactation

(2008) L. A. CHRISTENSEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

(2008) Deepa Reddy et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis

(2008) Judith M. Dalrymple et al.   ARTHRITIS AND RHEUMATISM

Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy

(2008) Dawn B. Beaulieu et al.   INFLAMMATORY BOWEL DISEASES

High-Dose Methylprednisolone in a Pregnant Woman with Crohn’s Disease and Adrenal Suppression in Her Newborn

(2008) Vesna Homar et al.   Neonatology

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis

(2007) Roja Rahimi et al.   REPRODUCTIVE TOXICOLOGY